TGFβ2‐Driven Ferritin Degradation and Subsequent Ferroptosis Underlie Salivary Gland Dysfunction in Postmenopausal Conditions
2024

Ferroptosis and Salivary Gland Dysfunction in Postmenopausal Women

Sample size: 14 publication 10 minutes Evidence: high

Author Information

Author(s): Oh Su‐Jeong, Shin Ye Young, Ahn Ji‐Su, Park Hee‐Jeong, Kang Min‐Jung, Shin Tae‐Hoon, Lee Byung‐Chul, Kim Won Kyu, Oh Jung‐Min, Lee Dongjun, Kim Yun Hak, Kim Ji Min, Sung Eui‐Suk, Lee Eun‐Woo, Jeong Jee‐Heon, Lee Byung‐Joo, Seo Yoojin, Kim Hyung‐Sik

Primary Institution: Pusan National University

Hypothesis

Is ferroptosis a key mechanism driving salivary gland dysfunction in postmenopausal conditions?

Conclusion

The study suggests that TGFβ signaling and ferroptosis are linked to salivary gland injury in postmenopausal women, and inhibiting ferroptosis can improve saliva secretion.

Supporting Evidence

  • Ferroptosis is linked to salivary gland dysfunction in postmenopausal women.
  • TGFβ2 treatment reduces ferritin levels, leading to ferroptosis in salivary gland organoids.
  • Administration of ferroptosis inhibitor Liproxstatin-1 improves saliva secretion in ovariectomized mice.
  • Enhanced TGFβ signaling is observed in the salivary glands of ovariectomized mice.
  • Histological changes in salivary glands include increased ductal compartments and reduced acinar cells.

Takeaway

When women go through menopause, their salivary glands can get damaged, leading to dry mouth. This study found that a specific type of cell death called ferroptosis is involved, and a special medicine can help fix this problem.

Methodology

The study used ovariectomized mouse models to investigate the role of ferroptosis in salivary gland dysfunction and assessed the effects of TGFβ2 treatment on salivary gland organoids.

Limitations

The study primarily used mouse models, and the findings may not fully translate to human conditions without further validation.

Participant Demographics

The study involved ovariectomized female mice, which model postmenopausal conditions.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1002/advs.202400660

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication